Better odds with 3 product to 1 don't you think???? And based on my research, RAP's chronic respiratory management for asthma and COPD is far superior than RSH's which is only for asthma......but DYOR.
- Forums
- ASX - By Stock
- RAP
- Ann: Change of Director's Interest Notice
Ann: Change of Director's Interest Notice, page-58
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 147 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)